Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Kingdon

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Human Psychopharmacology|August 14, 2015
Can cognitive behaviour therapy beneficially influence arousal mechanisms in psychosis?Fleur M Howells, David S Baldwin, David G Kingdon
Human Psychopharmacology|August 17, 2017
Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured reviewFleur M Howells, David G Kingdon, David S Baldwin
The Journal of Nervous and Mental Disease|June 10, 2010
Schizophrenia and borderline personality disorder: similarities and differences in the experience of auditory hallucinations, paranoia, and childhood traumaDavid G Kingdon, Katie Ashcroft, Bharathi Bhandari, et al.
Bjpsych Open|July 30, 2019
Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trialJames Shearer, Thomas R Lynch, Rampaul Chamba, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 19, 2019
Refractory depression - mechanisms and efficacy of radically open dialectical behaviour therapy (RefraMED): findings of a randomised trial on benefits and harmsThomas R Lynch, Roelie J Hempel, Ben Whalley, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Human Psychopharmacology|August 14, 2015
Can cognitive behaviour therapy beneficially influence arousal mechanisms in psychosis?Fleur M Howells, David S Baldwin, David G Kingdon
Human Psychopharmacology|August 17, 2017
Current and potential pharmacological and psychosocial interventions for anxiety symptoms and disorders in patients with schizophrenia: structured reviewFleur M Howells, David G Kingdon, David S Baldwin
The Journal of Nervous and Mental Disease|June 10, 2010
Schizophrenia and borderline personality disorder: similarities and differences in the experience of auditory hallucinations, paranoia, and childhood traumaDavid G Kingdon, Katie Ashcroft, Bharathi Bhandari, et al.
Bjpsych Open|July 30, 2019
Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trialJames Shearer, Thomas R Lynch, Rampaul Chamba, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 19, 2019
Refractory depression - mechanisms and efficacy of radically open dialectical behaviour therapy (RefraMED): findings of a randomised trial on benefits and harmsThomas R Lynch, Roelie J Hempel, Ben Whalley, et al.
Pageof 1